Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,233–4,240 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Veru Inc. Sabizabulin (VERU-111) - (VERACITY) Castration Resistant Prostate Cancer Phase 3 Trial Completed Oral Oncology
Veru Inc. Sabizabulin (VERU-111) - (VERACITY) Castration Resistant Prostate Cancer Phase 3 Trial Completed Oral Oncology
Veru Inc. Enobosarm - (ARTEST) ER+/HER2- breast cancer Phase 3 Looking for Funding oral Oncology
Veru Inc. Sabizabulin (VERU-111) COVID-19 / Severe Acute Respiratory Syndrome, SARS-CoV-2, Influenza A and B, Respiratory Syncytial Virus (RSV) and other viruses Phase 3 Trial Discontinued Oral COVID-19
Veru Inc. Sabizabulin (VERU-111) - (VERACITY) Castration Resistant Prostate Cancer Phase 3 Trial Completed Oral Oncology
Veru Inc. Enobosarm with semaglutide (Wegovy) - (PLATEAU) Obesity Phase 2b Trial Planned Oral Endocrinology
Veru Inc. Sabizabulin (VERU-111) Triple Negative Breast Cancer Phase 2b Trial Discontinued Oral Oncology
Veru Inc. VERU-100 Prostate cancer Phase 2 Trial Discontinued Subcutaneous Oncology